A Splice Site Variant of CDK12 and Breast Cancer in Three Eurasian Populations
CDK12 is a member of the cyclin-dependent kinase family that acts as regulator of DNA damage response gene expression. A c.1047-2A>G splice site variant of the CDK12 gene was recently reported to strongly associate with hereditary breast and ovarian cancer in patients of Tatar ethnic origin....
Main Authors: | Natalia V. Bogdanova, Peter Schürmann, Yana Valova, Natalia Dubrowinskaja, Nurzhan Turmanov, Tatyana Yugay, Zura Essimsiitova, Elvira Mingazheva, Darya Prokofyeva, Marina Bermisheva, Elza Khusnutdinova, Thilo Dörk |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-06-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2019.00493/full |
Similar Items
-
Targeted next-generation sequencing of 21 candidate genes in hereditary ovarian cancer patients from the Republic of Bashkortostan
by: D. S. Prokofyeva, et al.
Published: (2023-04-01) -
Mutation analysis of the ERCC4/FANCQ gene in hereditary breast cancer.
by: Sandra Kohlhase, et al.
Published: (2014-01-01) -
THE ROLE OF CROWDFUNDING IN THE FUTURE OF UKRAINE: PROBLEMS AND PROSPECTS
by: Natalia Grebeniuk, et al.
Published: (2023-12-01) -
Geographical Distribution, Incidence, Malignancies, and Outcome of 136 Eastern Slavic Patients With Nijmegen Breakage Syndrome and NBN Founder Variant c.657_661del5
by: Svetlana O. Sharapova, et al.
Published: (2021-01-01) -
Application of Breakage Models to Particle Speeds Simulated by Discrete Element Methods
by: M.A. Castro, et al.
Published: (2024-04-01)